Literature DB >> 18300411

The role of Egfl7 in vascular morphogenesis.

Maike Schmidt1, Ann De Mazière, Tanya Smyczek, Alane Gray, Leon Parker, Ellen Filvaroff, Dorothy French, Suzanne van Dijk, Judith Klumperman, Weilan Ye.   

Abstract

EGFL7 was identified by a number of groups as a putative secreted factor produced by the vascular endothelial cells (ECs). In a recent publication, we showed that EGFL7 regulates midline angioblast migration in zebrafish embryos-a key step in vascular tubulogenesis. In this study, we further characterized the zebrafish vasculature in the Egfl7 knockdown embryos at the ultrastructural level, and found that malformation of axial vessels is indeed due to the accumulation of angioblasts and aberrant connection among themselves, but not abnormal interaction between ECs and other cell types. Using in vitro biochemical assays, we demonstrated that EGFL7 is tightly associated with the extracellular matrix (ECM), and it supports EC migration either as a single factor or in combination with other ECM molecules. In order to evaluate if the biological function of EGFL7 is evolutionarily conserved, we generated Egfl7 knockout mice and analysed vascular development in a number of tissues. We found that vascular coverage of a given tissue is reduced or delayed, and vascular morphogenesis is defective in the Egfl7 mutant mice. Taken together, we conclude that EGFL7 provides a proper microenvironment for endothelial cell migration, thereby enabling accurate patterning. Our study indicates that the molecular composition of the ECM influences vascular morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18300411     DOI: 10.1002/9780470319413.ch3

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

1.  Expression and clinical significance of EGFL7 in malignant glioma.

Authors:  Chun-hai Huang; Xue-jun Li; Yi-zeng Zhou; Yong Luo; Cui Li; Xian-rui Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

2.  Attenuation of EGFL7 inhibits human laryngocarcinoma cells growth and invasion.

Authors:  Xiao-Xia Wang; Xiao-Bao Yao; Zhang-Shao Qiang; Hong-Liang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome.

Authors:  Bruno Henrique Bressan da Costa; Aline Paixão Becker; Luciano Neder; Paola Gyuliane Gonçalves; Cristiane de Oliveira; Allan Dias Polverini; Carlos Afonso Clara; Gustavo Ramos Teixeira; Rui Manuel Reis; Lucas Tadeu Bidinotto
Journal:  J Pathol Transl Med       Date:  2022-06-15

4.  The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.

Authors:  Yousef Salama; Andries Hendrik Heida; Kazuaki Yokoyama; Satoshi Takahashi; Koichi Hattori; Beate Heissig
Journal:  Blood Adv       Date:  2020-03-24

5.  VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.

Authors:  Chunhai Huang; Xianrui Yuan; Zhao Li; Zhi Tian; Xianquan Zhan; Jingjing Zhang; Xuejun Li
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

6.  miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Authors:  Nadia Felli; Federica Felicetti; Anna Maria Lustri; M Cristina Errico; Lisabianca Bottero; Alessio Cannistraci; Alessandra De Feo; Marina Petrini; Francesca Pedini; Mauro Biffoni; Ester Alvino; Massimo Negrini; Manuela Ferracin; Gianfranco Mattia; Alessandra Carè
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

7.  Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.

Authors:  Hongxia Chen; Lingmin Li; Shaojun Wang; Yupeng Lei; Qi Ge; Nonghua Lv; Xiaodong Zhou; Changyan Chen
Journal:  Oncotarget       Date:  2014-12-15

8.  An increase in elastogenic components in the placental villi of women with chronic venous disease during pregnancy is associated with decreased EGFL7 expression level.

Authors:  Miguel A Ortega; Ángel Asúnsolo; Oscar Fraile-Martínez; Felipe Sainz; Miguel A Saez; Coral Bravo; Juan A De León-Luis; Miguel A Alvarez-Mon; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

Review 9.  The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance.

Authors:  Beate Heissig; Yousef Salama; Satoshi Takahashi; Ko Okumura; Koichi Hattori
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.